Back to Journals » OncoTargets and Therapy » Volume 16

Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML

Total article views   HTML views PDF downloads Totals
3,130 Dovepress* 2,931+ 92 3,023
PubMed Central* 199 88 287
Totals 3,130 180 3,310
*Since 13 June 2023

View citations on PubMed Central and Google Scholar